Table 6.
Univariate analysis | Multivariate analysis | |||||||
HR | 95% CI | P value | HR | 95% CI | P value | |||
Age (yr) | 1.03 | (1.00–1.07) | .037 | 1.05 | (1.01–1.09) | .013 | ||
Gender (male vs female) | 0.85 | (0.40–1.84) | .687 | |||||
Body mass index, kg/m2 | 0.89 | (0.81–0.97) | .008 | 0.92 | (0.82–1.03) | .154 | ||
Chronic lung disease | 1.80 | (0.73–4.43) | .203 | |||||
Congestive heart failure | 1.88 | (0.91–3.90) | .090 | |||||
Coronary artery disease | 1.69 | (0.81–3.54) | .161 | |||||
Currently on dialysis | 2.69 | (1.29–5.61) | .008 | 4.38 | 10.18) | .001 | ||
GFR (mL/min) | 0.99 | (0.98–1.00) | .098 | |||||
Low density lipoprotein, mg/dL | 0.99 | (0.98–1.00) | .103 | |||||
Rutherford classification (6 vs 5) | 2.08 | (0.91–4.79) | .083 | |||||
Stenting | 2.28 | (1.09–4.76) | .028 | 1.56 | (0.64–3.81) | .328 | ||
Femoropopliteal drug-coating balloon | 1.07 | (0.37–3.07) | .906 | |||||
Infra-popliteal drug-coating balloon | 0.34 | (0.08–1.42) | .138 | |||||
Mean pre-EVT temperature of whole foot | 0.89 | (0.80–0.99) | .039 | 0.96 | (0.87–1.06) | .391 | ||
Mean post-EVT temperature of whole foot | 0.88 | (0.78–0.99) | .029 | |||||
DIFF1 | 1.11 | (0.84–1.47) | .474 | |||||
DIFF2 | 0.84 | (0.58–1.23) | .365 |